FEDERATED HERMES, INC. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$439
-99.0%
260
-98.3%
0.00%
Q2 2023$43,799
+9.4%
15,755
-28.4%
0.00%
Q1 2023$40,053
+264.1%
22,007
+1001.5%
0.00%
Q1 2022$11,000
-8.3%
1,998
+0.2%
0.00%
Q4 2021$12,000
-72.7%
1,995
-55.9%
0.00%
Q3 2021$44,000
-32.3%
4,524
-0.7%
0.00%
Q2 2021$65,000
+3150.0%
4,558
+4854.3%
0.00%
Q1 2021$2,000920.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders